← Back to Search

Behavioural Intervention

Active cTBS for Primary Insomnia

N/A
Recruiting
Led By William D Killgore, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Greater than or equal to 11 for ESS (Johns, 2000)
Healthy men and non-pregnant, non-lactating women 18-50 (inclusive) years of age, free from contraindicated diseases, medications, devices, and conditions.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the morning cognitive testing on overnight visit 2 (day 16)
Awards & highlights

Study Summary

This study is evaluating whether a type of brain stimulation can improve sleep habits in healthy individuals.

Eligible Conditions
  • Primary Insomnia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once during cognitive testing portion of overnight visit 2 (day 15-16), day 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and once during cognitive testing portion of overnight visit 2 (day 15-16), day 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of time spent in each sleep stage following administration of active or sham cTBS TMS
Sleep efficiency (SE) following administration of active or sham cTBS TMS - day 8-9
Sleep onset latency (SOL) following administration of active or sham cTBS TMS
+8 more
Secondary outcome measures
Actigraphy
California Verbal Learning Test Third Edition (CVLT-3) - day 15-16
California Verbal Learning Test Third Edition (CVLT-3) - day 8-9
+83 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sham cTBS first, then active cTBSExperimental Treatment2 Interventions
Participants complete an Enrollment Visit followed by one week of at-home actigraphy. Participants return to the lab for Overnight Visit 1 and undergo a MRI scan followed by sham cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep. Participants return home and complete another week of at-home actigraphy. Participants then return to the lab for Overnight Visit 2 where they undergo a MRI scan followed by active cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep.
Group II: Active cTBS first, then sham cTBSExperimental Treatment2 Interventions
Participants complete an Enrollment Visit followed by one week of at-home actigraphy. Participants return to the lab for Overnight Visit 1 and undergo a MRI scan followed by active cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep. Participants return home and complete another week of at-home actigraphy. Participants then return to the lab for Overnight Visit 2 where they undergo a MRI scan followed by sham cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sham cTBS
2016
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
511 Previous Clinical Trials
148,268 Total Patients Enrolled
William D Killgore, PhDPrincipal InvestigatorUniversity of Arizona
3 Previous Clinical Trials
150 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Mar 2025